{"filing":{"accession_number":"0001193125-26-316225","cik":"0000893949","ticker":"MD","company_name":"Pediatrix Medical Group, Inc.","form":"8-K","filing_date":"2026-07-24","report_date":"2026-07-21","primary_document":"md-20260721.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/893949/000119312526316225/md-20260721.htm"},"events":[{"id":20518,"run_id":18462,"accession_number":"0001193125-26-316225","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Ms. Mary Ann E. Moore, Executive Vice President, General Counsel, Chief Administrative Officer and Secretary, is departing the Company effective October 31, 2026, pursuant to a Separation Agreement executed on July 21, 2026, classified as a termination without cause with severance benefits.","company_name":"Pediatrix Medical Group, Inc.","ticker":"MD","filing_date":"2026-07-24","form":"8-K","submitted_at":null,"items":[{"id":19892,"accession_number":"0001193125-26-316225","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Ms. Mary Ann E. Moore, Executive Vice President, General Counsel, Chief Administrative Officer and Secretary, is departing the Company effective October 31, 2026, pursuant to a Separation Agreement executed on July 21, 2026. The departure is classified as a termination without cause, and Moore will receive severance benefits under her employment agreement. This is a material departure of a named executive officer holding multiple senior leadership roles.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T21:01:49.851425+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":20519,"run_id":18462,"accession_number":"0001193125-26-316225","anchor_item_number":"7.01","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Mr. David Haddock has been appointed as Executive Vice President, General Counsel and Secretary of Pediatrix Medical Group, Inc., assuming the senior leadership role vacated by Ms. Moore's departure.","company_name":"Pediatrix Medical Group, Inc.","ticker":"MD","filing_date":"2026-07-24","form":"8-K","submitted_at":null,"items":[{"id":19893,"accession_number":"0001193125-26-316225","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Mr. David Haddock as Executive Vice President, General Counsel and Secretary of Pediatrix Medical Group, Inc. This is a material executive appointment to a senior officer position responsible for legal and corporate governance functions. The appointment of a named executive to a C-suite role is a material event affecting the registrant's leadership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T21:01:49.851425+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":19892,"accession_number":"0001193125-26-316225","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Ms. Mary Ann E. Moore, Executive Vice President, General Counsel, Chief Administrative Officer and Secretary, is departing the Company effective October 31, 2026, pursuant to a Separation Agreement executed on July 21, 2026. The departure is classified as a termination without cause, and Moore will receive severance benefits under her employment agreement. This is a material departure of a named executive officer holding multiple senior leadership roles.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T21:01:49.851425+00:00","company_name":"Pediatrix Medical Group, Inc.","ticker":"MD","filing_date":"2026-07-24"},{"id":19893,"accession_number":"0001193125-26-316225","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Mr. David Haddock as Executive Vice President, General Counsel and Secretary of Pediatrix Medical Group, Inc. This is a material executive appointment to a senior officer position responsible for legal and corporate governance functions. The appointment of a named executive to a C-suite role is a material event affecting the registrant's leadership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T21:01:49.851425+00:00","company_name":"Pediatrix Medical Group, Inc.","ticker":"MD","filing_date":"2026-07-24"}]}